...
首页> 外文期刊>Tissue engineering, Part A >Expansion and delivery of adipose-derived mesenchymal stem cells on three microcarriers for soft tissue regeneration.
【24h】

Expansion and delivery of adipose-derived mesenchymal stem cells on three microcarriers for soft tissue regeneration.

机译:脂肪来源的间充质干细胞在三种微载体上的扩增和递送,用于软组织再生。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cell/microcarrier combinations can be injected to repair tissue defects, but whether currently available microcarriers can be utilized to repair different tissue defects remains unknown. Here, we compared the suitability of fabricated micronized acellular dermal matrix (MADM), micronized small intestinal submucosa (MSIS), and gelatin microspheres as expansion and delivery scaffolds for adipose-derived mesenchymal stem cells (ADSCs). The results of MTS assay, scanning electron microscopy (SEM), and flow cytometry suggested that the three microcarriers all have good biocompatibility. Quantitative polymerase chain reaction revealed enhanced epidermal growth factor, vascular endothelial growth factor, basal fibroblast growth factor, and transforming growth factor-beta expression levels after ADSCs had been cultured on MADM or MSIS for 5 days. After culturing ADSCs on microcarriers in osteogenic medium for 7 days, the expression levels of bone formation-related genes were enhanced. ADSC/microcarrier treatment accelerated wound closure. The ADSC/MADM and ADSC/MSIS combinations retained more of the original implant volume at 1 month postimplantation than ADSC/gelatin microspheres combination in soft-tissue augmentation studies. All implants displayed fibroblast and capillary vessel infiltrations; but ectopic bone formation did not occur, and the calvarial defect repair results were unfavorable. Our study demonstrates the potential utility of these microcarriers not only as a cell-culture substrate but also as a cell-transplantation vehicle for skin regeneration and soft-tissue reconstruction.
机译:可以注射细胞/微载体组合以修复组织缺损,但是尚不清楚当前可用的微载体是否可以用于修复不同的组织缺损。在这里,我们比较了制造的微粉化脱细胞真皮基质(MADM),微粉化小肠粘膜下层(MSIS)和明胶微球作为脂肪来源的间充质干细胞(ADSCs)的扩展和递送支架的适用性。 MTS分析,扫描电子显微镜(SEM)和流式细胞仪的结果表明,这三种微载体均具有良好的生物相容性。定量聚合酶链反应显示在ADDMs在MADM或MSIS中培养5天后,表皮生长因子,血管内皮生长因子,基底成纤维细胞生长因子和转化生长因子β表达水平增强。在成骨培养基中的微载体上培养ADSC 7天后,骨形成相关基因的表达水平提高。 ADSC /微载体治疗加速伤口闭合。在软组织增强研究中,ADSC / MADM和ADSC / MSIS组合在植入后1个月保留了比ADSC /明胶微球组合更多的原始植入物体积。所有植入物均显示成纤维细胞和毛细血管浸润。但未发生异位骨形成,颅骨缺损修复效果不佳。我们的研究表明,这些微载体的潜在用途不仅可以用作细胞培养基质,还可以用作皮肤再生和软组织重建的细胞移植载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号